For: | Chevallay M, Wassmer CH, Iranmanesh P, Jung MK, Mönig SP. Multimodal treatment in oligometastatic gastric cancer. World J Gastrointest Oncol 2022; 14(2): 434-449 [PMID: 35317315 DOI: 10.4251/wjgo.v14.i2.434] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i2/434.htm |
Number | Citing Articles |
1 |
Yuehong Cui, Yiyi Yu, Song Zheng, Jie’er Ying, Yi’an Du, Yan Wang, Xuefei Wang, Zhenbin Shen, Fenglin Liu, Minzhi Lv, Yihong Sun, Tianshu Liu. Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA). BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10773-x
|
2 |
Thifhelimbilu Luvhengo, Thulo Molefi, Demetra Demetriou, Rodney Hull, Zodwa Dlamini. Artificial Intelligence and Precision Oncology. 2023; : 49 doi: 10.1007/978-3-031-21506-3_3
|
3 |
Atsuto Katano, Hideomi Yamashita. Long-Term Survival After Repeated Salvage Chemoradiation Therapy for Metastatic Lymph Node Recurrence in Advanced Gastric Cancer: A Case Report. Cureus 2023; doi: 10.7759/cureus.36649
|
4 |
Hampig Raphael Kourie, Mervat Mahrous, Nabih Naim, Joseph Zouein, Zineb Benbrahim, Kakil Rasul, Mohsen Mokhtar, Ahmad Al Shehri, Mahmoud Shakeeb, Sami Khatib, Humaid Al-Shamsi, Ali Shamseddine, Elisabeth Smyth. The first Middle East and North Africa expert consensus recommendations for management of advanced gastric cancer. Future Oncology 2023; 19(21): 1451 doi: 10.2217/fon-2023-0219
|
5 |
Daniele Marrelli, Stefania Angela Piccioni, Ludovico Carbone, Roberto Petrioli, Maurizio Costantini, Valeria Malagnino, Giulio Bagnacci, Gabriele Rizzoli, Natale Calomino, Riccardo Piagnerelli, Maria Antonietta Mazzei, Franco Roviello. Posterior and Para-Aortic (D2plus) Lymphadenectomy after Neoadjuvant/Conversion Therapy for Locally Advanced/Oligometastatic Gastric Cancer. Cancers 2024; 16(7): 1376 doi: 10.3390/cancers16071376
|
6 |
Sander J. M. van Hootegem, Carlo A. de Pasqual, Simone Giacopuzzi, Elke Van Daele, Hanne Vanommeslaeghe, Johnny Moons, Philippe Nafteux, Pieter C. van der Sluis, Sjoerd M. Lagarde, Bas P. L. Wijnhoven. Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study. Cancers 2024; 16(4): 797 doi: 10.3390/cancers16040797
|
7 |
Paulo Pimentel de ASSUMPÇÃO, Jéssica Manoelli Costa da SILVA, Danielle Queiroz CALCAGNO, Williams Fernandes BARRA, Geraldo ISHAK, Paulo KASSAB. OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2023; 36 doi: 10.1590/0102-672020230034e1752
|
8 |
Magdalena Scheck, Sylvie Lorenzen. Medikamentöse Therapiestrategien des Magenkarzinoms . TumorDiagnostik & Therapie 2024; 45(03): 161 doi: 10.1055/a-2241-7192
|
9 |
M. A Reschke, U. Neumann, D. P. Hoyer. Präzisionsmedizinischer Ansatz für die Metastasenchirurgie viszeraler Tumoren. Die Onkologie 2024; 30(10): 932 doi: 10.1007/s00761-024-01583-2
|
10 |
Thorsten Goetze, Mickael Chevallay, Michel Dosch, Jordan Marcelis, Salah-Eddin Al-Batran, Stefan Paul Mönig. Oligometastatic disease – a renaissance for surgery?. Innovative Surgical Sciences 2024; doi: 10.1515/iss-2023-0044
|
11 |
Magdalena Scheck, Sylvie Lorenzen. Medikamentöse Therapiestrategien des Magenkarzinoms. Gastroenterologie up2date 2023; 19(03): 261 doi: 10.1055/a-1984-6886
|